Middle East gains breast cancer blood test
This article was originally published in Clinica
US company Power3 Medical Products has launched its breast cancer diagnostic blood test BC-SeraPro in 12 Middle Eastern countries. The Texas-based company (The Woodlands) expects the test to be performed in conjunction with mammography, and believes that it will help reduce the number of patients subjected to erroneous results from mammograms - which is allegedly 50% of women screened in the US.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.